DataMeds AI Shareholders Approve 1,000,000 Blank-Check Preferred Shares

• DataMeds AI shareholders adopted four corporate actions by written consent dated August 25, 2026.
• The charter amendment authorizes 1,000,000 shares of blank check preferred stock.
• Shareholders authorized common stock issuances to Silverback Capital under the January 28, 2026, settlement agreement beyond Nasdaq's 20% threshold.
• Five incumbent directors were reelected to serve until the 2027 annual meeting.
• Suri & Co. was ratified as independent auditor for the fiscal year ending December 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-050812), on November 09, 2026, and is solely responsible for the information contained therein.